Adma Biologics reported $35.12M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Adma Biologics ADMA:US $ 35.12M 1.71M
Agile Therapeutics AGRX:US 17.06M 775K
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Biocryst Pharmaceuticals BCRX:US $ 85.58M 6.04M
China Cord Blood CO:US 153.22M 5.4M
Dynavax Technologies DVAX:US $ 92.2M 43.38M
Kindred Biosciences KIN:US 12.08M 520K
Minerva Neurosciences NERV:US $ 7.52M 1.45M
Novavax NVAX:US $ 485.99M 157.86M
Omeros OMER:US $ 48.26M 4.58M
Takeda 4502:JP 747.39B 46.34B